Single dose of Vivani’s NPM-139 semaglutide ... generated weight loss of approximately 20% compared to a sham implant control after a 28-day treatment duration. Price Action: VANI stock closed ...

1 Multiple trials, including hundreds of obese/overweight women in the menopausal/postmenopausal age group, reflect weight loss of at least 5% with three months of semaglutide treatment.

While gastrointestinal issues are the most common side effects, a recent study by the University of British Columbia linked ...